Find the latest news about ScreenPlus research Publications and Latest News Publications Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots – DOI: https://doi.org/10.1038/s41436-020-01017-5 A highly multiplexed biochemical assay for analytes in dried blood spots: application to newborn screening and diagnosis of lysosomal storage disorders and other inborn errors of metabolism – DOI: https://doi.org/10.1038/s41436-020-0790-9 Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots – DOI: https://doi.org/10.1038/s41436-020-0846-x The future of newborn screening for lysosomal disorders – DOI: https://doi.org/10.1016/j.neulet.2021.136080 Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders – DOI: https://doi.org/10.3390/ijns8040059 ScreenPlus: A comprehensive, dynamic, multi-disorder newborn screening pilot program - DOI: https://doi.org/10.1016/j.ymgme.2019.11.426 The New York pilot newborn screening program for lysosomal storage diseases: Report of the first 65,000 Infants — DOI: https://doi.org/10.1038/s41436-018-0129-y International Scientific Presentations SSIEM, Freiburg, Germany, August 2022: ScreenPlus: A model of collective funding of pilot newborn screening (poster) MLD Alliance conference in Florence, Italy, November 2022: MLD Screening in ScreenPlus Brazilian Congress of Medical Genetics and Brazilian Congress of Neonatal Screening in Sao Paulo, Brazil, August 2023: Expansion of Neonatal Screening: Risk and Benefits of Genomics ICoNS in London, United Kingdom, October 2023: Optimizing Consent Rate in Pilot Newborn Screening Studies MLD Alliance Conference in Vienna, Austria, November 2023: ScreenPlus: MLD Screening and Outcomes in ScreenPlus National Scientific Presentations World Orphan Drug Conference, May 2020: ScreenPlus Overview Association of Public Health Laboratories (APHL), November 2020: ScreenPlus Overview New York State Newborn Screening Program Metabolic Specialty Care Center Meeting, June 2022: ScreenPlus: Opportunities of a Multi-Disease Pilot Newborn Screening Program International Niemann-Disease Association and NNPDF Meetings, July 2022: ScreenPlus: Opportunities of a Multi-Disease Pilot Newborn Screening Program International Consortium of Newborn Sequencing (ICoNS), October 2022: ScreenPlus: An Overview of Infrastructure and ELSI Studies APHL Newborn Screening Symposium, October 2022: Developing an Integrated, Mixed-Methods Parent Engagement Research Program: The ScreenPlus ELSI Studies APHL Newborn Screening Symposium, October 2022: ScreenPlus: A Pilot Study to Screen for 14 Disorders; Overview, Challenges, and Preliminary Results MLD Alliance Conference, November 2022: MLD Screening in ScreenPlus New York State Genetic Task Force, September 2023: ScreenPlus Pilot Newborn Screening: Latest Developments and Parental Perspectives 13th Annual Lysosomal Storage Disease Conference, December 2023: Newborn Screening for Lysosomal Storage Diseases Advisory Committee on Heritable Disorders in Newborns and Children meeting, January 2024: ScreenPlus ELSI data WORLD Conference, February 2024: A Parent’s Journey to Consent: An analysis of the number and mode of attempts used to gain consent from the first 11,000 ScreenPlus participants National Academies of Science, Engineering, and Medicine (NASEM) workshop, March 2024: Newborn Screening: Current Landscape and Future Directions Ara Parseghian Medical Research Fund (APMRF) conference, June 2024: ScreenPlus: A Consented, Multi-tiered, Multi-disorder Pilot Newborn Screening Program
